Literature DB >> 26952020

Use of transient elastography in patients with HIV-HCV coinfection: A systematic review and meta-analysis.

Basile Njei1,2, Thomas R McCarty3, Jeffrey Luk3, Oforbuike Ewelukwa4, Ivo Ditah5, Joseph K Lim6.   

Abstract

BACKGROUND AND AIM: Patients with HIV-hepatitis C virus (HCV) coinfection progress towards liver fibrosis and cirrhosis more rapidly compared with HCV mono-infected individuals. This necessitates an accurate assessment of liver stiffness with transient elastography to guide treatment.
METHODS: Searches of PubMed, EMBASE, Web of Science, and the Cochrane Library databases were performed through January 2016 to assess the diagnostic accuracy of transient elastography for liver stiffness in the HIV-HCV population. Included studies were analyzed according to the Cochrane DTA Working Group methodology. Bivariate and hierarchical models were used to compute pooled sensitivity and specificity. Positive and negative likelihood ratios were also determined. A Fagan nomogram was constructed. Meta-regression analysis was performed with assessment of publication bias using Deeks' funnel plot asymmetry testing.
RESULTS: A total of six studies (n = 756) met the inclusion criteria. The diagnostic accuracy of elastography for the diagnosis of moderate (≥F2) fibrosis was 88% (95% confidence interval [CI], 0.85-0.90). The pooled sensitivity and specificity of moderate fibrosis was 97% (95% CI, 0.82-0.91) and 64% (95% CI, 0.45-0.79), respectively. The diagnostic accuracy of elastography for the assessment of cirrhosis was 94% (95% CI, 0.91-0.95). The pooled sensitivity and specificity for cirrhosis was 90% (95% CI, 0.74-0.97) and 87% (95% CI, 0.80-0.92), respectively. Meta-regression analysis demonstrated that CD4 cell count did not impact diagnostic accuracy of elastography.
CONCLUSIONS: Transient elastography is a noninvasive imaging modality with excellent ability to assess for cirrhosis in patients with HIV-HCV coinfection.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  HCV; HIV; elastography; fibrosis; hepatitis

Mesh:

Year:  2016        PMID: 26952020      PMCID: PMC5014713          DOI: 10.1111/jgh.13337

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  38 in total

1.  How should meta-regression analyses be undertaken and interpreted?

Authors:  Simon G Thompson; Julian P T Higgins
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors:  Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.

Authors:  Mirella Fraquelli; Cristina Rigamonti; Giovanni Casazza; Dario Conte; Maria Francesca Donato; Guido Ronchi; Massimo Colombo
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

4.  A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

Authors:  Yen Ngo; Mona Munteanu; Djamila Messous; Frederic Charlotte; Françoise Imbert-Bismut; Dominique Thabut; Pascal Lebray; Vincent Thibault; Yves Benhamou; Joseph Moussalli; Vlad Ratziu; Thierry Poynard
Journal:  Clin Chem       Date:  2006-08-24       Impact factor: 8.327

5.  HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.

Authors:  Juan A Pineda; Manuel Romero-Gómez; Fernando Díaz-García; José A Girón-González; José L Montero; Julián Torre-Cisneros; Raúl J Andrade; Mercedes González-Serrano; José Aguilar; Manuela Aguilar-Guisado; José M Navarro; Javier Salmerón; Francisco J Caballero-Granado; José A García-García
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

6.  Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

Authors:  Julien Vergniol; Juliette Foucher; Eric Terrebonne; Pierre-Henri Bernard; Brigitte le Bail; Wassil Merrouche; Patrice Couzigou; Victor de Ledinghen
Journal:  Gastroenterology       Date:  2011-03-02       Impact factor: 22.682

7.  Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Authors:  Thomas B Kelleher; Shruti H Mehta; Ramakrishnan Bhaskar; Mark Sulkowski; Jacquie Astemborski; David L Thomas; Richard E Moore; Nezam H Afdhal
Journal:  J Hepatol       Date:  2005-04-25       Impact factor: 25.083

8.  Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

Authors:  Susanna Naggie; Curtis Cooper; Michael Saag; Kimberly Workowski; Peter Ruane; William J Towner; Kristen Marks; Anne Luetkemeyer; Rachel P Baden; Paul E Sax; Edward Gane; Jorge Santana-Bagur; Luisa M Stamm; Jenny C Yang; Polina German; Hadas Dvory-Sobol; Liyun Ni; Phillip S Pang; John G McHutchison; Catherine A M Stedman; Javier O Morales-Ramirez; Norbert Bräu; Dushyantha Jayaweera; Amy E Colson; Pablo Tebas; David K Wong; Douglas Dieterich; Mark Sulkowski
Journal:  N Engl J Med       Date:  2015-07-21       Impact factor: 91.245

9.  Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

Authors:  Gregory D Kirk; Jacquie Astemborski; Shruti H Mehta; Chuck Spoler; Cedric Fisher; Danisha Allen; Yvonne Higgins; Richard D Moore; Nezem Afdhal; Michael Torbenson; Mark Sulkowski; David L Thomas
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

10.  Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.

Authors:  Jürgen K Rockstroh; Mark Nelson; Christine Katlama; Jay Lalezari; Josep Mallolas; Mark Bloch; Gail V Matthews; Michael S Saag; Philippe J Zamor; Chloe Orkin; Jacqueline Gress; Stephanie Klopfer; Melissa Shaughnessy; Janice Wahl; Bach-Yen T Nguyen; Eliav Barr; Heather L Platt; Michael N Robertson; Mark Sulkowski
Journal:  Lancet HIV       Date:  2015-07-09       Impact factor: 16.070

View more
  8 in total

Review 1.  Noninvasive imaging assessment of portal hypertension.

Authors:  Paul Kennedy; Octavia Bane; Stefanie J Hectors; Aaron Fischman; Thomas Schiano; Sara Lewis; Bachir Taouli
Journal:  Abdom Radiol (NY)       Date:  2020-09-14

Review 2.  Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.

Authors:  Paul Kennedy; Mathilde Wagner; Laurent Castéra; Cheng William Hong; Curtis L Johnson; Claude B Sirlin; Bachir Taouli
Journal:  Radiology       Date:  2018-03       Impact factor: 11.105

Review 3.  Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.

Authors:  Eric G Meissner
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

4.  Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease - could we strike while the liver is hard?

Authors:  Gil Ben Yakov; Disha Sharma; Hawwa Alao; Pallavi Surana; Devika Kapuria; Ohad Etzion; Matthew M Hsieh; John F Tisdale; Courtney D Fitzhugh; David E Kleiner; Elliot B Levy; Richard Chang; Elenita Rivera; Amy Huang; Christopher Koh; Theo Heller
Journal:  Br J Haematol       Date:  2019-06-19       Impact factor: 8.615

5.  Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals.

Authors:  Mihály Sulyok; Tamás Ferenci; Mihály Makara; Gábor Horváth; János Szlávik; Zsófia Rupnik; Luca Kormos; Zsuzsanna Gerlei; Zita Sulyok; István Vályi-Nagy
Journal:  PeerJ       Date:  2017-01-11       Impact factor: 2.984

6.  Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection.

Authors:  Saverio Giuseppe Parisi; Monica Basso; Carlo Mengoli; Renzo Scaggiante; Samantha Andreis; Marzia Maria Franzetti; Anna Maria Cattelan; Daniela Zago; Mario Cruciani; Massimo Andreoni; Sara Piovesan; Giorgio Palù; Alfredo Alberti
Journal:  Ann Gastroenterol       Date:  2017-07-04

7.  Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients.

Authors:  Evy Yunihastuti; Bramantya Wicaksana; Andrian Wiraguna; Ainum Jhariah Hidayah; Fhadilla Amelia; Veritea Natali; Alvina Widhani; Andri Sanityoso Sulaiman; Juferdy Kurniawan
Journal:  BMC Infect Dis       Date:  2020-05-25       Impact factor: 3.090

8.  Impact of illicit opioid use on markers of monocyte activation and systemic inflammation in people living with HIV.

Authors:  Anastasia Kholodnaia; Kaku So-Armah; Debbie Cheng; Natalia Gnatienko; Gregory Patts; Jeffrey H Samet; Matthew Freiberg; Dmitry Lioznov
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.